Sign In
Buy ORTX
$16.70
+0 (+0%)
At Close: Mar 15, 2024
Why Infinity Pharma, Meridian Bio, More Biotech Stocks Are Moving Today
12:34pm, Friday, 05'th Feb 2021
Infinity Pharmaceuticals (NASDAQ: INFI) shares are trading higher Friday after JPMorgan upgraded the stock from Underweight to Neutral. Infinity Pharmaceuticals is a clinical-stage biopharmaceutical c
Orchard Therapeutics Announces $150 Million Strategic Financing
07:00am, Friday, 05'th Feb 2021
Strengthened Financial Position Supports Execution into the First Half of 2023 Strengthened Financial Position Supports Execution into the First Half of 2023
Orchard Therapeutics Appoints Braden Parker as Chief Commercial Officer
07:00am, Friday, 29'th Jan 2021
Commercial Launch of Libmeldy™ in Europe On-Track for 1H 2021 Commercial Launch of Libmeldy™ in Europe On-Track for 1H 2021
Orchard Therapeutics Secures Partnerships to Broaden Access to LibmeldyTM for Eligible Patients in Middle East & Turkey
07:00am, Tuesday, 19'th Jan 2021
BOSTON and LONDON, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced plans to extend the company's commercial reach in the Middle
Orchard (ORTX) Gets FDA's RMAT Status for Gene Therapy in MLD
09:47am, Friday, 15'th Jan 2021
The FDA bestows a Regenerative Medicine Advanced Therapy status on Orchard Therapeutics' (ORTX) investigational gene therapy, OTL-200, for treating early-onset metachromatic leukodystrophy. Shares up.
Orchard Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
07:00am, Tuesday, 05'th Jan 2021
BOSTON and LONDON, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the company is scheduled to present at the 39th Annual J.P.
Orchard Therapeutics Receives EC Approval for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
07:00am, Monday, 21'st Dec 2020
First gene therapy to receive full EU marketing authorization for eligible MLD patients
Bet on Rising P/E Investing With These Top 5 Stocks
08:17am, Friday, 18'th Dec 2020
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
Orchard Therapeutics Reports OTL-201 Initial Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA)
07:00am, Tuesday, 08'th Dec 2020
Preliminary results from first patient treated with OTL-201 show over expression of the therapeutic enzyme and decrease in substrate levels three months following gene therapy Preliminary results from
Orchard Therapeutics Announces FDA Clearance of IND Application for OTL-200 for Metachromatic Leukodystrophy (MLD)
07:00am, Thursday, 19'th Nov 2020
BOSTON and LONDON, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the U.S. Food and Drug Administration (FDA) has cleared the
Got $1,000? Invest in These 2 Rare Disease Stocks
05:47am, Tuesday, 17'th Nov 2020
These companies are devoted to helping patients who don't have any other options.
Orchard Therapeutics to Present at Barclays Gene Editing & Gene Therapy Summit
07:00am, Monday, 09'th Nov 2020
BOSTON and LONDON, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the company is scheduled to present at the Barclays Gene Ed
Preliminary results from first patient in ongoing proof-of-concept trial show evidence of engraftment of gene-modified cells three months following treatment Preliminary results from first patient in
Orchard Therapeutics: An Undervalued Stock With Upcoming Catalysts
08:41am, Wednesday, 04'th Nov 2020
Orchard just received a positive node from CHMP for its lead drug candidate. US approval should be next.
Orchard Therapeutics to Host Virtual R&D Investor Event on Friday, November 13, 2020
07:00am, Monday, 02'nd Nov 2020
BOSTON and LONDON, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the company will webcast a virtual R&D event ‘New Horizon
